Mannkind (MNKD) Gross Profit (QoQ) (2015 - 2026)
Mannkind (MNKD) Gross Profit (QoQ) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 65,839.48 Bn | 65,839.20 Bn | - |
| 2 | Nanobiotix | 1,933.82 Bn | 1,933.76 Bn | - |
| 3 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 4 | BeOne Medicines | 472.40 Bn | 467.61 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.23 Bn | 114.98 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 70.05 Bn | 61.29 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.46 Bn | 62.46 Bn | - |
| 8 | Argenx Se | 55.94 Bn | 50.76 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.52 Bn | 34.51 Bn | 959.66 Mn |
| 10 | Mannkind | 1.26 Bn | 1.12 Bn | 82.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.68% |
| Dec 31, 2025 | 26.27% |
| Sep 30, 2025 | 7.94% |
| Jun 30, 2025 | -3.57% |
| Mar 31, 2025 | 3.64% |
| Dec 31, 2024 | 7.60% |
| Sep 30, 2024 | 0.15% |
| Jun 30, 2024 | 6.95% |
| Mar 31, 2024 | -20.31% |
| Dec 31, 2023 | 107.23% |
| Sep 30, 2023 | -12.85% |
| Jun 30, 2023 | 23.62% |
| Mar 31, 2023 | 9.75% |
| Dec 31, 2022 | 65.83% |
| Sep 30, 2022 | 537.28% |
| Jun 30, 2022 | 511.14% |
| Mar 31, 2022 | 96.41% |
| Dec 31, 2021 | -211.28% |
| Sep 30, 2021 | -2.49% |
| Jun 30, 2021 | 43.81% |